Risk factors for mortality among patients diagnosed with multi-drug resistant tuberculosis in Uganda- a case-control study

BACKGROUND: The World Health Organization (WHO) End TB strategy aims to reduce mortality due to tuberculosis (TB) to less than 5% by 2035. However, mortality due to multidrug-resistant tuberculosis (MDR-TB) remains particularly high. Globally, almost 20% of patients started on MDR-TB treatment die d...

Descripción completa

Detalles Bibliográficos
Autores principales: Kizito, Enock, Musaazi, Joseph, Mutesasira, Kenneth, Twinomugisha, Fred, Namwanje, Helen, Kiyemba, Timothy, Freitas Lopez, Debora B., Nicholas, Nicholas Sebuliba, Nkolo, Abel, Birabwa, Estella, Dejene, Seyoum, Zawedde-Muyanja, Stella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986038/
https://www.ncbi.nlm.nih.gov/pubmed/33752637
http://dx.doi.org/10.1186/s12879-021-05967-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986038/
https://www.ncbi.nlm.nih.gov/pubmed/33752637
http://dx.doi.org/10.1186/s12879-021-05967-2

Ejemplares similares